The first connection between SCLC and the Hh signaling pathway [67] was the identification of a subset of SCLC cell lines that expressed SHH and GLI1 and whose growth in culture and in vivo xenografts were inhibited by the SMO antagonist, cyclopamine [99,187,188]. This evidence concerns the gene GLI1 and small cell lung carcinoma.